Cargando…
Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research
The aim of this study was to find the application value of selective polyadenylation in immune cell infiltration, biological transcription function and risk assessment of survival and prognosis in lung adenocarcinoma (LUAD). The processed original mRNA expression data of LUAD were downloaded, and th...
Autores principales: | Wu, Liusheng, Zhong, Yanfeng, Yu, Xiaoya, Wu, Dingwang, Xu, Pengcheng, Lv, Le, Ruan, Xin, Liu, Qi, Feng, Yu, Liu, Jixian, Li, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481295/ https://www.ncbi.nlm.nih.gov/pubmed/35946526 http://dx.doi.org/10.1097/CAD.0000000000001319 |
Ejemplares similares
-
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis
por: Wu, Liusheng, et al.
Publicado: (2022) -
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model
por: Wu, Liusheng, et al.
Publicado: (2021) -
Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
por: Wu, Liusheng, et al.
Publicado: (2023) -
Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model
por: Hou, Qinghua, et al.
Publicado: (2022) -
Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19
por: Wu, Liusheng, et al.
Publicado: (2021)